The "Therapeutic Window" of the "Atypical" Antipsychotic Paliperidone ER-A Positron Emission Tomography Study With [18F]Fallypride as the Radiotracer.

Trial Profile

The "Therapeutic Window" of the "Atypical" Antipsychotic Paliperidone ER-A Positron Emission Tomography Study With [18F]Fallypride as the Radiotracer.

Discontinued
Phase of Trial: Phase IV

Latest Information Update: 08 Apr 2014

At a glance

  • Drugs Paliperidone (Primary) ; Risperidone (Primary)
  • Indications Schizophrenia
  • Focus Pharmacokinetics
  • Sponsors Janssen-Cilag
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 21 Jul 2012 New source identified and integrated (European Clinical Trials Database record; EudraCT2008-003340-11).
    • 18 May 2010 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top